Literature DB >> 22508400

Meta-analysis of genetic polymorphisms in granulomatosis with polyangiitis (Wegener's) reveals shared susceptibility loci with rheumatoid arthritis.

Sharon A Chung1, Gang Xie, Delnaz Roshandel, Richard Sherva, Jeffrey C Edberg, Megan Kravitz, Paul F Dellaripa, Gary S Hoffman, Alfred D Mahr, Philip Seo, Ulrich Specks, Robert F Spiera, E William St Clair, John H Stone, Robert M Plenge, Katherine A Siminovitch, Peter A Merkel, Paul A Monach.   

Abstract

OBJECTIVE: To examine the association of previously identified autoimmune disease susceptibility loci with granulomatosis with polyangiitis (Wegener's) (GPA), and to determine whether the genetic susceptibility profiles of other autoimmune diseases are associated with those of GPA.
METHODS: Genetic data from 2 cohorts were meta-analyzed. Genotypes for 168 previously identified single-nucleotide polymorphisms (SNPs) associated with susceptibility to different autoimmune diseases were ascertained in a total of 880 patients with GPA and 1,969 control subjects of European descent. Single-marker associations were identified using additive logistic regression models. Associations of multiple SNPs with GPA were assessed using genetic risk scores based on susceptibility loci for Crohn's disease, type 1 diabetes, systemic lupus erythematosus, rheumatoid arthritis (RA), celiac disease, and ulcerative colitis. Adjustment for population substructure was performed in all analyses, using ancestry-informative markers and principal components analysis.
RESULTS: Genetic polymorphisms in CTLA4 were significantly associated with GPA in the single-marker meta-analysis (odds ratio [OR] 0.79, 95% confidence interval [95% CI] 0.70-0.89, P = 9.8 × 10(-5) ). The genetic risk score for RA susceptibility markers was significantly associated with GPA (OR 1.05 per 1-unit increase in genetic risk score, 95% CI 1.02-1.08, P = 5.1 × 10(-5) ).
CONCLUSION: RA and GPA may arise from a similar genetic predisposition. Aside from CTLA4, other loci previously found to be associated with common autoimmune diseases were not statistically significantly associated with GPA in this study.
Copyright © 2012 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2012        PMID: 22508400      PMCID: PMC3425721          DOI: 10.1002/art.34496

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  68 in total

1.  The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary.

Authors:  J F Fries; G G Hunder; D A Bloch; B A Michel; W P Arend; L H Calabrese; A S Fauci; R Y Leavitt; J T Lie; R W Lightfoot
Journal:  Arthritis Rheum       Date:  1990-08

Review 2.  Genetics of ulcerative colitis.

Authors:  Alexandra I Thompson; Charlie W Lees
Journal:  Inflamm Bowel Dis       Date:  2010-11-12       Impact factor: 5.325

3.  Genome-wide association study of rheumatoid arthritis in Koreans: population-specific loci as well as overlap with European susceptibility loci.

Authors:  Jan Freudenberg; Hye-Soon Lee; Bok-Ghee Han; Hyoung Do Shin; Young Mo Kang; Yoon-Kyoung Sung; Seung-Cheol Shim; Chan-Bum Choi; Annette T Lee; Peter K Gregersen; Sang-Cheol Bae
Journal:  Arthritis Rheum       Date:  2011-04

4.  Polymorphisms in CTLA-4 but not tumor necrosis factor-alpha or interleukin 1beta genes are associated with Wegener's granulomatosis.

Authors:  D Huang; R Giscombe; Y Zhou; A K Lefvert
Journal:  J Rheumatol       Date:  2000-02       Impact factor: 4.666

5.  Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies.

Authors:  H K Choi; S Liu; P A Merkel; G A Colditz; J L Niles
Journal:  J Rheumatol       Date:  2001-07       Impact factor: 4.666

6.  Coding sequence 1 and promoter single nucleotide polymorphisms in the CTLA-4 gene in Wegener's granulomatosis.

Authors:  Ricardo Giscombe; Xiongbiao Wang; Deren Huang; Ann Kari Lefvert
Journal:  J Rheumatol       Date:  2002-05       Impact factor: 4.666

7.  Strong link between the alpha 1-antitrypsin PiZ allele and Wegener's granulomatosis.

Authors:  A N Elzouki; M Segelmark; J Wieslander; S Eriksson
Journal:  J Intern Med       Date:  1994-11       Impact factor: 8.989

8.  An analysis of CTLA-4 and proinflammatory cytokine genes in Wegener's granulomatosis.

Authors:  Yihua Zhou; DeRen Huang; Pamela L Paris; Craig S Sauter; Kristin A Prock; Gary S Hoffman
Journal:  Arthritis Rheum       Date:  2004-08

9.  An allele of IKZF1 (Ikaros) conferring susceptibility to childhood acute lymphoblastic leukemia protects against type 1 diabetes.

Authors:  Austin D-E Swafford; Joanna M M Howson; Lucy J Davison; Chris Wallace; Deborah J Smyth; Helen Schuilenburg; Meeta Maisuria-Armer; Trupti Mistry; Michael J Lenardo; John A Todd
Journal:  Diabetes       Date:  2011-01-26       Impact factor: 9.461

10.  Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47.

Authors:  Carl A Anderson; Gabrielle Boucher; Charlie W Lees; Andre Franke; Mauro D'Amato; Kent D Taylor; James C Lee; Philippe Goyette; Marcin Imielinski; Anna Latiano; Caroline Lagacé; Regan Scott; Leila Amininejad; Suzannah Bumpstead; Leonard Baidoo; Robert N Baldassano; Murray Barclay; Theodore M Bayless; Stephan Brand; Carsten Büning; Jean-Frédéric Colombel; Lee A Denson; Martine De Vos; Marla Dubinsky; Cathryn Edwards; David Ellinghaus; Rudolf S N Fehrmann; James A B Floyd; Timothy Florin; Denis Franchimont; Lude Franke; Michel Georges; Jürgen Glas; Nicole L Glazer; Stephen L Guthery; Talin Haritunians; Nicholas K Hayward; Jean-Pierre Hugot; Gilles Jobin; Debby Laukens; Ian Lawrance; Marc Lémann; Arie Levine; Cecile Libioulle; Edouard Louis; Dermot P McGovern; Monica Milla; Grant W Montgomery; Katherine I Morley; Craig Mowat; Aylwin Ng; William Newman; Roel A Ophoff; Laura Papi; Orazio Palmieri; Laurent Peyrin-Biroulet; Julián Panés; Anne Phillips; Natalie J Prescott; Deborah D Proctor; Rebecca Roberts; Richard Russell; Paul Rutgeerts; Jeremy Sanderson; Miquel Sans; Philip Schumm; Frank Seibold; Yashoda Sharma; Lisa A Simms; Mark Seielstad; A Hillary Steinhart; Stephan R Targan; Leonard H van den Berg; Morten Vatn; Hein Verspaget; Thomas Walters; Cisca Wijmenga; David C Wilson; Harm-Jan Westra; Ramnik J Xavier; Zhen Z Zhao; Cyriel Y Ponsioen; Vibeke Andersen; Leif Torkvist; Maria Gazouli; Nicholas P Anagnou; Tom H Karlsen; Limas Kupcinskas; Jurgita Sventoraityte; John C Mansfield; Subra Kugathasan; Mark S Silverberg; Jonas Halfvarson; Jerome I Rotter; Christopher G Mathew; Anne M Griffiths; Richard Gearry; Tariq Ahmad; Steven R Brant; Mathias Chamaillard; Jack Satsangi; Judy H Cho; Stefan Schreiber; Mark J Daly; Jeffrey C Barrett; Miles Parkes; Vito Annese; Hakon Hakonarson; Graham Radford-Smith; Richard H Duerr; Séverine Vermeire; Rinse K Weersma; John D Rioux
Journal:  Nat Genet       Date:  2011-02-06       Impact factor: 38.330

View more
  16 in total

Review 1.  Biological Therapy-Induced Systemic Vasculitis.

Authors:  Luis Arturo Gutiérrez-González
Journal:  Curr Rheumatol Rep       Date:  2016-07       Impact factor: 4.592

2.  Association of granulomatosis with polyangiitis (Wegener's) with HLA-DPB1*04 and SEMA6A gene variants: evidence from genome-wide analysis.

Authors:  Gang Xie; Delnaz Roshandel; Richard Sherva; Paul A Monach; Emily Yue Lu; Tabitha Kung; Keisha Carrington; Steven S Zhang; Sara L Pulit; Stephan Ripke; Simon Carette; Paul F Dellaripa; Jeffrey C Edberg; Gary S Hoffman; Nader Khalidi; Carol A Langford; Alfred D Mahr; E William St Clair; Philip Seo; Ulrich Specks; Robert F Spiera; John H Stone; Steven R Ytterberg; Soumya Raychaudhuri; Paul I W de Bakker; Lindsay A Farrer; Christopher I Amos; Peter A Merkel; Katherine A Siminovitch
Journal:  Arthritis Rheum       Date:  2013-09

Review 3.  Mechanisms of vascular damage in ANCA vasculitis.

Authors:  David Massicotte-Azarniouch; Carolina A Herrera; J Charles Jennette; Ronald J Falk; Meghan E Free
Journal:  Semin Immunopathol       Date:  2022-03-07       Impact factor: 11.759

Review 4.  ANCA-associated vasculitis with renal involvement.

Authors:  Valentina Binda; Gabriella Moroni; Piergiorgio Messa
Journal:  J Nephrol       Date:  2017-05-30       Impact factor: 3.902

Review 5.  ANCA-associated vasculitis - clinical utility of using ANCA specificity to classify patients.

Authors:  Divi Cornec; Emilie Cornec-Le Gall; Fernando C Fervenza; Ulrich Specks
Journal:  Nat Rev Rheumatol       Date:  2016-07-28       Impact factor: 20.543

6.  Association of ETS1 polymorphism with granulomatosis with polyangiitis and proteinase 3-anti-neutrophil cytoplasmic antibody positive vasculitis in a Japanese population.

Authors:  Aya Kawasaki; Keita Yamashita; Fumio Hirano; Ken-Ei Sada; Daisuke Tsukui; Yuya Kondo; Yoshitaka Kimura; Kurumi Asako; Shigeto Kobayashi; Hidehiro Yamada; Hiroshi Furukawa; Kenji Nagasaka; Takahiko Sugihara; Kunihiro Yamagata; Takayuki Sumida; Shigeto Tohma; Hajime Kono; Shoichi Ozaki; Seiichi Matsuo; Hiroshi Hashimoto; Hirofumi Makino; Yoshihiro Arimura; Masayoshi Harigai; Naoyuki Tsuchiya
Journal:  J Hum Genet       Date:  2017-10-05       Impact factor: 3.172

Review 7.  Genetic Susceptibility to ANCA-Associated Vasculitis: State of the Art.

Authors:  Francesco Bonatti; Michele Reina; Tauro Maria Neri; Davide Martorana
Journal:  Front Immunol       Date:  2014-11-17       Impact factor: 7.561

Review 8.  Advances in the genomics of ANCA-associated vasculitis-a view from East Asia.

Authors:  Aya Kawasaki; Naoyuki Tsuchiya
Journal:  Genes Immun       Date:  2021-03-08       Impact factor: 2.676

9.  Anti-neutrophil cytoplasmic antibodies in rheumatoid arthritis: two case reports and review of literature.

Authors:  David Spoerl; Yves-Marie Pers; Christian Jorgensen
Journal:  Allergy Asthma Clin Immunol       Date:  2012-12-19       Impact factor: 3.406

10.  Successful application of extracorporeal membrane oxygenation due to pulmonary hemorrhage secondary to granulomatosis with polyangiitis.

Authors:  Wolfgang Hohenforst-Schmidt; Arndt Petermann; Aikaterini Visouli; Paul Zarogoulidis; Kaid Darwiche; Ioanna Kougioumtzi; Kosmas Tsakiridis; Nikolaos Machairiotis; Markus Ketteler; Konstantinos Zarogoulidis; Johannes Brachmann
Journal:  Drug Des Devel Ther       Date:  2013-07-24       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.